Note that some links may require subscriptions
If you were planning to hand out black licorice to trick-or-treaters tonight, don’t eat too much of it yourself. (FDA)
Questions abound as the Obamacare enrollment period for 2018 starts tomorrow. (Los Angeles Times)
Could Obamacare plans no longer be a financial loser for insurers? Aetna said it may have turned the corner in the last quarter. (Reuters)
But they can still be a pain in the neck for consumers who fail to dot their i’s and cross their t’s properly. (Kaiser Health News)
Another study ties regular aspirin use to reduced GI cancer risk. (United European Gastroenterology)
Regeneron and Sanofi said their IL-4/13 inhibitor dupilumab was effective in asthma patients, reducing flares and steroid use in patients with severe disease.
FDA Commissioner Scott Gottlieb, MD, said the agency is exploring new technology-based ways to keep people from abusing opioids, with a public workshop scheduled for Dec. 11-12.
A two-day FDA advisory panel meeting starting today will review two long-acting formulations of buprenorphine, which could reshape the opioid addiction treatment landscape.
Resistance to the “invasion of computers of healthcare” is not futile, says Taison Bell, MD, on KevinMD.
Is there anything that women can’t be persuaded to smear into their vaginas? Dr. Jen Gunter examines the latest cringe-inducing fad.
Modern Healthcare has your Halloween list of haunted hospitals and other medical buildings.
Morning Break is a daily guide to what’s new and interesting on the Web for healthcare professionals, powered by the MedPage Today community. Got a tip? Send it to us: MPT_editorial@everydayhealthinc.com.